Aziyo Biologics Inc - Ordinary Shares - Class A

NASDAQ:AZYO   4:00:00 PM EDT
6.90
+0.11 (+1.62%)
4:15:07 PM EDT: $5.60 -1.30 (-18.84%)
Earnings Announcements

Aziyo Biologics Reports Strong Third Quarter 2022 Revenue

Published: 11/14/2022 21:23 GMT
Aziyo Biologics Inc - Ordinary Shares - Class A (AZYO) - Aziyo Biologics Reports Strong Third Quarter 2022 Revenue.
Q3 Sales Rose 8 Percent to $12.4 Million.
Sees Total Net Sales for the Full Year 2022 in the Range of $48 Million to $50 Million.
Qtrly Net Loss per Share Basic and Diluted $0.73.
Q3 Earnings per Share View $-0.66, Revenue View $12.4 Million -- Refinitiv Ibes Data (analyst estimates).
FY2022 Revenue View $49.3 Million -- Refinitiv Ibes Data (analyst estimates).
Revenue is expected to be $12.49 Million
Adjusted EPS is expected to be -$0.64

Next Quarter Revenue Guidance is expected to be $12.35 Million
Next Quarter EPS Guidance is expected to be -$0.55

More details on our Analysts Page.